Skip to main content
Friday
November 29, 2024
Sign In
Subscribe
Home
Epaper
Economy
Aviation
Banking
Bazaar
Budget
Industry
NBR
RMG
Corporates
Stocks
Analysis
Videos
Podcast
World+Biz
Features
Book Review
Brands
Earth
Explorer
Food
Habitat
In Focus
Luxury
Mode
Panorama
Pursuit
Wheels
Subscribe
Epaper
GOVT. Ad
More
Sports
TBS Graduates
Thoughts
Splash
Bangladesh
Supplement
Infograph
Archive
Gallery
Long Read
Interviews
Offbeat
Tech
Magazine
Climate Change
Health
Cartoons
বাংলা
FRIDAY,
NOVEMBER 29, 2024
J&J
World+Biz
J&J and Merck Ebola vaccines produce lasting antibodies in children and adults -studies
Coronavirus chronicle
No Omicron deaths in J&J vaccine study in South Africa, scientist says
Global Economy
Healthcare giant Johnson & Johnson to split into two companies
Coronavirus chronicle
US brokers J&J-COVAX deal to send vaccines to conflict zones -Blinken
USA
J&J settles most Risperdal lawsuits, with $800 million in expenses
Coronavirus chronicle
US FDA clears Moderna, J&J Covid-19 boosters, backs use of different vaccine for boost
Coronavirus chronicle
Moderna or Pfizer booster works better for people vaccinated with J&J: study
USA
Six US states do not join $26 billion opioid settlements with distributors, J&J
Coronavirus chronicle
J&J says US FDA agrees to extend shelf life of its Covid-19 vaccine
World+Biz
J&J exploring putting talc liabilities into bankruptcy
World+Biz
J&J reaches $230 mln opioid settlement with New York state
Panorama
The real vaccine crisis isn’t about J&J or AstraZeneca
Coronavirus chronicle
J&J to deliver Covid vaccine to Europe from April 19
Show More